Mauss S, et al (2017). Late presentation of chronic viral hepatitis for medical care: a consensus definition. BMC Medicine (2017) 15:92
Lazarus JV et al. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe. Croatian Medical Journal 2016 Oct 31;57(5):442-456.
Bell S, et al. (2016) HIV pre-test information, discussion or counselling? A review of guidance relevant to the WHO European Region. International Journal of STD & AIDS 27(2): 97-104.
Raben D, et al. on behalf of the Study Group. (2015) Auditing: Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study. PLOS ONE 10(11).
Lazarus JV, et al. on behalf of the HIV in Europe Initiative Steering Committee. (2013) The case for indicator condition-guided HIV screening. HIV Medicine 14(7): 445-8.
Mocroft A, et al. for the Collaboration of Observational HIV Epidemiological Research Groups (COHERE) study in EuroCoord. (2013) Risk Factors and Outcomes for Late Presentation for HIV- positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLOS Medicine 10(9)
Sullivan A, et al. (2013) Feasibility and Effectiveness of Indicator Condition Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study). PLOS ONE 8(1)
Lazarus JV, et al. (2011) Overcoming obstacles to late presentation for HIV infection in Europe. HIV Medicine 12(4): 246-9.
Phillips A, et al. for the Working Group on Estimation of HIV Prevalence in Europe. (2011) HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV. AIDS 25:1017-1023.
Antinori A, et al. for the European Late Presenter Consensus working group. (2010) Late presentation of HIV infection: a consensus definition. HIV Medicine 12(1): 61-4